ARTICLE | Company News
Enzon and Schering-Plough submit sBLA
February 6, 2001 8:00 AM UTC
ENZN and partner SGP submitted a supplemental BLA to the FDA for PEG-Intron peginterferon alfa-2b powder for injection in combination with Rebetol ribavirin capsules to treat chronic hepatitis C in pa...